Lithium As a Treatment to Prevent Impairment of Cognition in Elders
Status:
Recruiting
Trial end date:
2024-05-31
Target enrollment:
Participant gender:
Summary
Alzheimer's disease (AD) is the most common cause of dementia in adults 65 years and older.
AD leads to a complete loss of memory and independent function, and presently there is no
cure. Many studies suggest that lithium treatment may delay dementia onset or slow its
progression. However, more research is needed to understand the extent of its anti-dementia
properties if it will be deployed broadly in the general population. This study will examine
whether lithium has anti-dementia properties in older adults who have mild cognitive
impairment and are at risk of becoming demented.